OncoDaily

???The Second Global OncoThon: A Day of Unity and Action for Pediatric Cancer OncoDaily, in partnership with the International Society of Paediatric Oncology - SIOP , is excited to announce the Second Global OncoThon, a 24-hour virtual event aimed at raising essential funds and awareness for pediatric cancer research. Set for February 15, 2025, to coincide with Childhood Cancer Awareness Day, this global initiative will unite people and organizations worldwide with a common goal: ensuring a future free of cancer for every child.??? Despite being one of the leading causes of disease-related death in children, childhood cancer receives significantly less research funding than adult cancers. With nearly half a million new diagnoses every year, pediatric cancer is often classified as a “rare disease,” limiting the resources allocated to it. While over 200 drugs are available for adult cancers, fewer than 30 have been developed specifically for children, illustrating the critical gap in treatment options. This funding shortage hampers innovation, delaying the development of life-saving treatments and leaving children worldwide without the advancements they desperately need. The Second Global OncoThon focuses not on statistics but on real, human stories – the child with hopes of a future, the parent committed to never giving up, and the global community that can make a tangible difference. This event will be a day of connection, compassion, and action, uniting us to declare that no child should ever face cancer alone. It is our moment to inspire change and deliver the breakthroughs every child deserves. Save the date and join us for this pivotal day of solidarity and progress. One Day. One Mission. One Global Effort.??? Join the Second Global OncoThon by OncoDaily: https://lnkd.in/gvYGaM4A Donate now: https://lnkd.in/dvC64XYn Princess Dina Mired #Cancer #Oncothon #OncothonChallenge #ChildhoodCancer #CancerFundraising #PediatricOncology #CancerSupport #MedNews #Health #Medicine #OncoDaily #Oncology

Kick-starting our new project, FAST-ABCD - PD Dr. Oliver Henke, M.Sc. Kilimanjaro Christian Medical Center (KCMC) Universit?tsklinikum Bonn #OncoDaily #Oncology #Cancer #Health #Medicine #FASTABCD #NanoporeSequencing #BreastCancer

Honored to be this year's recipient of the MOASC Cary Presant YIA award - Peter Zang Medical Oncology Association of Southern California, Inc. City of Hope #OncoDaily #Oncology #Cancer #Health #Medicine #CaryPresantYIAAward #MOASCAnnualSummit25

Amivantamab plus Lazertinib vs. Osimertinib in 1L EGFRm Advanced NSCLC - Hidehito Horinouchi https://lnkd.in/eqjfCRve #NSCLC #LungCancer #ELCC25 #Cancer #OncoDaily #Medicine #Oncology

Julie Gralow on How EveryGrant Supports Funders in Creating World-Class Programs – Conquer Cancer, the ASCO Foundation https://lnkd.in/dRdhR5qC #OncoDaily #Oncology #Cancer #Health #Medicine #ConquerCancer #EveryGrant

So proud of Neal Chawla who delivered a terrific talk at MOASC Annual Summit 25 - Sumanta Pal, MD, FASCO City of Hope https://lnkd.in/eeHXuKwr #CityofHope #MOASC #Cancer #OncoDaily #Medicine #Oncology

Oncology dealmakers seek multi-indication therapies - Aakash Desai, MD, MPH #OncoDaily #Oncology #Cancer #Health #Medicine #PrecisionOncology

Association of Cancer Care Centers's new podcast episode with Wade Swenson Carolyn Trachtenbroit Jasmine Kamboj, MD, FASCO #OncoDaily #Oncology #Cancer #Health #Medicine #ACCC

cfDNA fragmentomics is redefining cancer detection - Diego A. Díaz García https://lnkd.in/eXs4mz-N #CancerDetection #LiquidBiopsy #Cancer #OncoDaily #Medicine #Oncology

This study uncovers the potential of CD4+ T cells to complement CD8+ T cells and NK cells - Jun Kim Bastian Kruse https://lnkd.in/diWmqRNq #Nature #Cancer #OncoDaily #Medicine #Oncology